Cargando…
A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment
The initial responses to standard chemotherapies among prostate cancer (PCa) patients are usually significant, while most of them will finally develop drug resistance, rendering them with limited therapies. To discover new regimens for the treatment of PCa including resistant PCa, natural products,...
Autores principales: | Ji, Xiaozhen, Liu, Kai, Li, Qingyue, Shen, Qun, Han, Fangxuan, Ye, Qingmei, Zheng, Caijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962830/ https://www.ncbi.nlm.nih.gov/pubmed/35359832 http://dx.doi.org/10.3389/fphar.2022.851589 |
Ejemplares similares
-
Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
por: Ye, Qingmei, et al.
Publicado: (2023) -
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
por: Ye, Qingmei, et al.
Publicado: (2019) -
An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
por: Ye, Qingmei, et al.
Publicado: (2023) -
Plant Flavone Apigenin Binds to Nucleic Acid Bases and Reduces Oxidative DNA Damage in Prostate Epithelial Cells
por: Sharma, Haripaul, et al.
Publicado: (2014) -
Construction and Screening of Fractional Library of Salviae Miltiorrhizae Radix et Rhizoma for the Rapid Identification of Active Compounds against Prostate Cancer
por: Ye, Qing-Mei, et al.
Publicado: (2022)